欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子抑制剂 > PI3K/Akt/mTORsignaling > BEZ235 (Tosylate)

浏览历史

S81732

BEZ235 (Tosylate)

源叶(MedMol) 99%
  • 英文名:
  • BEZ235 (Tosylate)
  • 别名:
  • BEZ235 Tosylate||BEZ-235 Tosylate; NVP-BEZ235 tosylate; NVP-BEZ235-ANA; 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile monotosylate; Dacto
  • CAS号:
  • 1028385-32-1
  • 分子式:
  • C37H31N5O4S
  • 分子量:
  • 641.7382
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S81732-10mg 99% ¥410.00元 预计交期:2-3天 - - - EA 加入购物车
源叶(MedMol) S81732-50mg 99% ¥880.00元 预计交期:2-3天 - - - EA 加入购物车
源叶(MedMol) S81732-100mg 99% ¥1400.00元 预计交期:2-3天 - - - EA 加入购物车
源叶(MedMol) S81732-500mg 99% ¥3900.00元 预计交期:2-3天 - - - EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献(1篇)

质检证书(COA)

摩尔浓度计算器

相关产品

  • 提示:详情请下载说明书。
  • 产品描述: Dactolisib Tosylate (BEZ235 Tosylate) is a dual PI3K and mTOR kinase inhibitor with IC50 values of 4, 75, 7, 5 nM for PI3Kα, β, γ, δ, respectively. Dactolisib Tosylate (BEZ235 Tosylate) inhibits mTORC1 and mTORC2
  • 靶点: p110α:4 nM (IC50);p110α-H1047R:4.6 nM (IC50);p110α-E545K:5.7 nM (IC50);p110γ:5 nM (IC50);p110δ;7 nM (IC50);p110β:75 nM (IC50);mTOR:20.7 nM (IC50);mTORC1;mTORC2;Autophagy;PI3K; mTOR
  • 体外研究:
    Dactolisib (BEZ235) is an imidazo[4,5-c]quinoline derivative that inhibits PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes. The IC50s for PI3Kα, β, γ, δ are 4, 75, 7, 5 nM, respectively. It is also found to be as active against the mutant PI3KαE545K or PI3KαH1047R with IC50s of 5.7 and 4.6 nM, respectively. In human tumor cell lines, it is able to effectively and specifically block the dysfunctional activation of the PI3K pathway, inducing G1 arrest. PTEN-null cell lines PC3M and U87MG shows a dose-dependent reduction in cell proliferation when treated with increasing concentrations of Dactolisib (BEZ235), with an average GI50 of 10 to 12 nM
  • 体内研究:
    Dactolisib (BEZ235) is well tolerated, displays disease stasis when administered orally, and enhances the efficacy of other anticancer agents. At a dose of 50 mg/kg, Dactolisib (BEZ235) appears rapidly in plasma with a Cmax of 1.68 μM at 0.5 h and a C24h of 0.03 μM
  • 参考文献:
    1. Maira SM, et al. Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. Mol Cancer Ther, 2008, 7(7), 1851-1863.
  • 溶解性: soluble  in  DMSO
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 1.558 ml 7.791 ml 15.583 ml
    5 mM 0.312 ml 1.558 ml 3.117 ml
    10 mM 0.156 ml 0.779 ml 1.558 ml
    50 mM 0.031 ml 0.156 ml 0.312 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。